References
- Wakabayashi K, Tanji K, Mori F, Takahashi H. The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of α-synuclein aggregates. Neuropathology27(5), 494–506 (2007).
- Goedert M. α-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci.2(7), 492–501 (2001).
- Vila M, Ramonet D, Perier C. Mitochondrial alterations in Parkinson’s disease: new clues. J. Neurochem.107(2), 317–328 (2008).
- Miller RM, Federoff HJ. Microarrays in Parkinson’s disease: a systematic approach. NeuroRx3(3), 319–326 (2006).
- Eberwine J, Belt B, Kacharmina JE, Miyashiro K. Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem. Res.27(10), 1065–1077 (2002).
- Crino PB, Eberwine J. Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis. Neuron17(6), 1173–1187 (1996).
- Pfeiffer BE, Huber KM. Current advances in local protein synthesis and synaptic plasticity. J. Neurosci.26(27), 7147–7150 (2006).
- Barrett LE, Sul JY, Takano H, Van Bockstaele EJ, Haydon PG, Eberwine JH. Region-directed phototransfection reveals the functional significance of a dendritically synthesized transcription factor. Nat. Methods3(6), 455–460 (2006).